Stimly develops proprietary neuromodulation technologies to treat anxiety and smoking cravings. The company’s wearable provides an alternative to pharmaceutical therapies, associated with potential side adverse effects.
Exclusively for clinical investigation.
Employees
1-10Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
